Literature DB >> 27861235

Brief Report: Prolonged Viral Suppression Over a 12-Year Follow-up of HIV-Infected Patients: The Persistent Impact of Adherence at 4 Months After Initiation of Combined Antiretroviral Therapy in the ANRS CO8 APROCO-COPILOTE Cohort.

Camelia Protopopescu1, Maria P Carrieri, François Raffi, Odile Picard, Lucile Hardel, Lionel Piroth, Corinne Jadand, Janine Pierret, Bruno Spire, Catherine Leport.   

Abstract

The effect of early adherence on long-term viral suppression was assessed among 1281 patients with HIV starting a protease inhibitor-containing regimen in 1997-1999, followed up to 12 years. Association between 4-month adherence (3-level score) and prolonged viral suppression was evaluated using a multivariate mixed logistic model in 891 eligible patients. High 4-months adherence [odds ratio (95% confidence interval): 3.72 (1.98 to 6.98)] was associated with long-term prolonged viral suppression, irrespective of maintenance adherence. This unexpected long-term virological impact of early adherence reinforces the message that, when starting antiretrovirals, all means should be mobilized to ensure optimum early adherence to achieve prolonged antiretroviral success.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27861235     DOI: 10.1097/QAI.0000000000001249

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  8 in total

1.  Long-term clinical, immunological and virological outcomes of patients on antiretroviral therapy in southern Myanmar.

Authors:  Elkin Hernán Bermúdez-Aza; Sharmila Shetty; Janet Ousley; Nang Thu Thu Kyaw; Theint Thida Soe; Kyipyar Soe; Phyu Ei Mon; Kyaw Tin Tun; Iza Ciglenecki; Susanna Cristofani; Marcelo Fernandez
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

2.  Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study.

Authors:  Atika Moosa; Tanuja N Gengiah; Lara Lewis; Kogieleum Naidoo
Journal:  BMC Infect Dis       Date:  2019-09-05       Impact factor: 3.090

3.  Emerging priorities for HIV service delivery.

Authors:  Nathan Ford; Elvin Geng; Tom Ellman; Catherine Orrell; Peter Ehrenkranz; Izukanji Sikazwe; Andreas Jahn; Miriam Rabkin; Stephen Ayisi Addo; Anna Grimsrud; Sydney Rosen; Isaac Zulu; William Reidy; Thabo Lejone; Tsitsi Apollo; Charles Holmes; Ana Francisca Kolling; Rosina Phate Lesihla; Huu Hai Nguyen; Baker Bakashaba; Lastone Chitembo; Ghion Tiriste; Meg Doherty; Helen Bygrave
Journal:  PLoS Med       Date:  2020-02-14       Impact factor: 11.069

4.  Switching protease inhibitors to rilpivirine in HIV-positive individuals with complete viral suppression and without prior HIV drug resistance in a resource-limited setting: a randomized controlled trial.

Authors:  Kulissara Palanuphap; Somnuek Sungkanuparph
Journal:  J Int AIDS Soc       Date:  2020-04       Impact factor: 5.396

5.  Predictors of loss to follow-up from HIV antiretroviral therapy in Namibia.

Authors:  Steven Y Hong; Anna Winston; Nicholus Mutenda; Ndapewa Hamunime; Tuhin Roy; Christine Wanke; Alice M Tang; Michael R Jordan
Journal:  PLoS One       Date:  2022-04-14       Impact factor: 3.240

6.  Benefits and risks of rapid initiation of antiretroviral therapy.

Authors:  Nathan Ford; Chantal Migone; Alexandra Calmy; Bernhard Kerschberger; Steve Kanters; Sabin Nsanzimana; Edward J Mills; Graeme Meintjes; Marco Vitoria; Meg Doherty; Zara Shubber
Journal:  AIDS       Date:  2018-01-02       Impact factor: 4.177

7.  Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.

Authors:  Collins Iwuji; Nuala McGrath; Alexandra Calmy; Francois Dabis; Deenan Pillay; Marie-Louise Newell; Kathy Baisley; Kholoud Porter
Journal:  J Int AIDS Soc       Date:  2018-06       Impact factor: 5.396

8.  Interactive Mobile Phone HIV Adherence Support for Men Who Have Sex With Men in the Philippines Connect for Life Study: Mixed Methods Approach to Intervention Development and Pilot Testing.

Authors:  Cara O'Connor; Katerina Leyritana; Aoife M Doyle; James J Lewis; Randeep Gill; Edsel Maurice Salvaña
Journal:  JMIR Form Res       Date:  2022-02-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.